The Liège-based company Contipharma has filed a patent for a rapid saliva-based antigen test for malaria detection, a world first.
Contipharma, a pharmaceutical company specializing in the development and commercialization of targeted medical solutions, now offers a rapid saliva-based malaria detection test.
This is what the Liège-based company Contipharma has successfully developed, having just filed a patent for a rapid non-invasive diagnostic test addressing the challenges encountered with current detection tools.
This is a world first, but above all, it was a priority for Contipharma: developing a test that provides major diagnostic support in the fight against malaria perfectly aligned with the founding mission that Contipharma has pursued from the beginning.
